vimarsana.com

Page 7 - ஸ்ரீ சித்ரா திருனல் நிறுவனம் க்கு மருத்துவ அறிவியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Sri Chitra Institute develops India s first flow diverter stent, transfers tech

Technology > Health & Medicine 21 January 2021 Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), has entered into technology transfer agreements with Pune-based Biorad Medisys for two biomedical implant devices - an Atrial Septal Defect Occluder and an Intracranial Flow Diverter Stents. The country’s first indigenous device for correcting ballooning of brain arteries and device for healing of heart hole has been developed by the institute in collaboration with National Aerospace Laboratories, Bangalore (CSIR-NAL) using superelastic NiTiNOL alloys. CSTIMST is an autonomous institute of the Department of Science & Technology (DST), under the Technical Research Centre (TRC),  Dr K Jayakumar, director, SCTIMST, and Jitendra Hedge, managing director, Biorad Medisys, signed the technology transfer agreements in the presence of Dr Jitendra J Jadhav, director, CSIR- NAL, through an online meeting early this week.

MPs take up issue of free treatment of infants under RBSK

MPs take up issue of free treatment of infants under RBSK Updated: Updated: Centre urged to resolve impasse between NHM and SCTIMST Share Article Centre urged to resolve impasse between NHM and SCTIMST Members of the Parliament from the State, K. Muraleedharan and Kodikkunnil Suresh, have written to Union Health Minister Harsh Vardhan, demanding that the Centre intervene to resolve the impasse between National Health Mission (NHM) and Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), which has virtually put a halt to the free treatment offered to children with critical congenital illnesses at the SCTIMST under the Rashtriya Bal Swasthya Karyakram (RBSK).

SCTIMST-NHM standoff puts lives of many infants in balance

Payment due to SCTIMST under RBSK now stands at ₹20 crore The lives of hundreds of infants with serious congenital heart disease (CHD) is hanging in the balance as the National Health Mission (NHM) and the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST) are engaged in a war of words over reimbursement of medical bills for corrective surgeries done for the infants under the Rashtriya Bal Swasthya Karyakram (RBSK). Since 2014, under the RBSK, a national initiative, thousands of children with congenital defects from across the country have undergone complex surgeries in tertiary care speciality centres such as SCTIMST and selected empanelled private hospitals in the State.

Asha Kishore quits SCTIMST - The Hindu

Asha Kishore quits SCTIMST Updated: Updated: Share Article AAA Asha Kishore, former director of the Sree Chitra Tirunal Institute for Medical Sciences and Technology (SCTIMST), has chosen to quit the job at the institute. Her application for the voluntary retirement scheme (VRS) was approved by the president of the institute, an official communication said on Friday. Dr. Kishore is a Senior Professor in the Department of Neurology of the SCTIMST. She will be relieved from service on December 9, the date on which the High Court of Kerala dismissed her appeal challenging a Central Administrative Tribunal order cancelling the extension of her tenure as director of the SCTIMST.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.